Clinical Trials Browser

Phase 2 × OTHER × Myeloid Malignancies × Clear all

NCT06668584 2026-03-04

A Phase II Open-label Study of Olutasidenib Post-transplant Maintenance Therapy for Patients With IDH1-mutated Myeloid Malignancies

Phase 2 Recruiting

Myeloid Malignancies

NCT02452697 2024-02-20

NK-DCI

Phase 2 Unknown

36 enrolled 11 charts

Myeloid Malignancies

NCT05807659 2023-04-11

Fractionated Busulfan Conditioning Regimen for Allo-HSCT in Non-remission Myeloid Malignancies

Phase 2 Unknown

Myeloid Malignancies